半胱天冬酶-1作为眼表损伤生物标志物的作用
这项横断面研究分析了113份泪液样本(64名受试者),包括干眼病组、使用青光眼药物组和对照组,用酶联免疫吸附试验检测泪液中半胱天冬酶-1水平。结果显示眼表损伤者泪液半胱天冬酶-1水平高于对照组,与角膜染色和眼红呈正相关,与Schirmer试验和泪膜破裂时间呈负相关,且检测眼表损伤的敏感性和AUC高于InflammaDry。
要点
- 眼表损伤者泪液半胱天冬酶-1水平高于对照组。
- 半胱天冬酶-1与角膜染色呈中度正相关(Spearman r=0.31;P=.001)。
- 半胱天冬酶-1检测眼表损伤的敏感性和AUC高于InflammaDry,且不受抗炎药物影响。
核心结论
- 眼表损伤个体泪液中半胱天冬酶-1水平较高,提示其有潜力作为生物标志物和/或治疗靶点。
研究设计与样本
- 横断面研究,共分析113份泪液样本(64名受试者)。
- 61份样本来自干眼病(DED)个体,定义为眼表疾病指数(OSDI)≥13和/或角膜染色(CS)≥3。
- 32份样本来自使用青光眼药物的个体,不论DED指标如何。
- 20份样本来自对照组(CS<3且OSDI<13)。
- 所有个体完成病史表格和眼表评估,用酶联免疫吸附试验检测Schirmer试纸条上的半胱天冬酶-1蛋白水平。
主要发现
- 人群平均年龄58±18岁,70%为女性。
- 眼表损伤个体泪液样本的半胱天冬酶-1水平高于对照组。
- 半胱天冬酶-1与角膜染色呈中度正相关(Spearman r=0.31;P=.001),与眼红呈中度正相关(Spearman r=0.39;P=.004)。
- 半胱天冬酶-1与Schirmer试验呈负相关(Spearman r=-0.46;P<.001),与泪膜破裂时间呈负相关(Spearman r=-0.33;P=.0006)。
- 半胱天冬酶-1检测眼表损伤的敏感性和AUC高于InflammaDry,其表达不受抗炎药物影响。
关键数值与推荐
- 干眼病定义为OSDI≥13和/或CS≥3。
- 对照组定义为CS<3且OSDI<13。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the potential of caspase-1 as a biomarker for ocular surface damage. DESIGN: Cross-sectional study. METHODS: A total of 113 tear samples (64 subjects) were analyzed. Sixty-one samples were from individuals with dry eye disease (DED), defined as Ocular Surface Disease Index (OSDI) ≥13 and/or corneal staining (CS) ≥3; 32 were from individuals who used glaucoma medication, irrespective of DED metrics; and 20 were from controls (CS <3 and OSDI <13). All individuals completed a medical history form and underwent an ocular surface assessment. Protein levels of caspase-1 were determined by enzyme-linked immunosorbent assay off Schirmer's strips. The primary analysis compared caspase-1 levels in individuals with signs of ocular surface damage (CS ≥3) in both case groups and controls. Secondary correlational analyses were conducted to examine relationships between caspase-1 levels and ocular signs and symptoms. Finally, area under the curve (AUC) analyses were performed to examine relationships between inflammatory markers and CS. RESULTS: The mean age of the population was 58±18 years; 70% were female. Tear samples from individuals with ocular surface damage presented higher caspase-1 levels than the control group. Caspase-1 levels showed a moderate positive correlation with CS (Spearman r = 0.31; P = .001) and eye redness (Spearman r = 0.39; P = .004), and a negative correlation with Schirmer's (Spearman r = -0.46; P < .001) and tear break-up time (Spearman r = -0.33; P = .0006). Caspase-1 showed higher sensitivity and AUC for detecting ocular surface damage than InflammaDry, and its expression was not affected by anti-inflammatory agents. CONCLUSION: Caspase-1 levels were higher in the tears of individuals with ocular surface damage, suggesting its potential to be used as a biomarker and/or therapeutic target.
引用
- Tovar A, Gomez A, Serrano A, et al. Role of Caspase-1 as a Biomarker of Ocular Surface Damage. Am J Ophthalmol. 2022. PMID: 35151638. doi:10.1016/j.ajo.2022.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。